The treatment options (Table 1) for breast cancer are commonly dependent on the presence of tumor, lymph node involvement, metastasis, staging, histological grade, hormone receptor status, ERBB2 (formerly HER2 or HER2/neu) overexpression, and menopausal status. This evidence concerns the gene ERBB2 and breast carcinoma.